the aid library

LIST OPTIONS

Filter

10067

Sistema de salud en Venezuela: ¿un paciente sin remedio?

Alejandra Carrillo Roa (2018) CC

The health system in Venezuela: a patient without medication? Cad. Saúde Pública 34 (3) 05 Mar 2018 • https://doi.org/10.1590/0102-311X00058517

External Link

How to safely collect sputum samples from patients suspected to be infected with pneumonic plague

World Health Organization WHO (2016) C_WHO

Interim Guidance

Download (1567)

View PDF (2120)

How to safely conduct burial of patient who has died from suspected or confirmed Marburg or Ebola viurs disease: field situation

World Health Organization (2014)

This protocol provides information on the safe management of dead bodies and burial of patients who died from suspected or confirmed Ebola virus disease. These measures should be applied not only by medical personnel but by anyone involved in the management of dead bodies and burial of suspected o... more

Download (348)

View PDF (431)

Scaling up policies, interventions, and measurement for stigma-free HIV prevention, care and treatment services

A. Jain; L. Nyblade PEPFAR; USAID; Health Policy Project (2012) C2

Policy July 2012 Working Paper No. 3

Download (263)

View PDF (281)

Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave

B. C. Zanoni; M. Archary; S. Buchan; I. T. Katz; J. E. Haberer BMJ Global Health; Pub Med (2016) C2

Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004

Download (338)

View PDF (283)

Guide pédagogique de l’OMS pour la sécurité des patients

World Health Organisation (WHO) (2011) C_WHO

Le secteur de la santé a beaucoup évolué au cours des 20 dernières années. Les innovations technologiques ainsi que notre connaissance des maladies ont contribué à allonger l’espérance de vie au 20ème siècle. Cependant, l’un des plus grands défis aujourd’hui n’est pas de rester a... more

Download (1022)

View PDF (2201)

Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care - WHO interim guidelines

World Health Organization WHO (2007) C_WHO

These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and control for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infr... more

Download (309)

View PDF (377)

Imaging ultrasound before 24 weeks of pregnancy: 2022 update to the WHO antenatal care recommendations for a positive pregnancy experience

World Health Organization WHO (2022) C_WHO

This technical brief describes the re-affirmed WHO recommendation on ultrasound examination in the context of routine antenatal care and outlines policy and programme implications for translating this recommendation into action at the country level.

External Link

Desarrollo de la práctica de farmacia - Centrada en la atención del paciente

Wiedenmayer, K. et al. Organización Mundial de la Salud (OMS), Federación Internacional Farmacéutica (FIP) (2006) CC

Spanish version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Este manual de introducción marca un nuevo paradigma en la práctica de farmacia. Intenta guiar a los formadores en atención farmacéutica para educar a los estudiantes de farmacia y a los farmacéuticos ya estableci... more

Download (206)

View PDF (210)

Effectiveness of a diabetes program based on digital health on capacity building and quality of care in type 2 diabetes: a pragmatic quasi-experimental study

Moreas Morelli, D.; Rubinstein, F.; Santero, M.; et al. BMC Health Services Research, part of Springer Nature (2023) CC2

Health systems in Latin America face many challenges in controlling the increasing burden of diabetes. Digital health interventions are a promise for the provision of care, especially in developing countries where mobile technology has a high penetration. This study evaluated the effectiveness of th... more

Download (773)

View PDF (629)

Guidelines for the Development of Pharmaceutical Services in Primary Health Care

Pan American Health Organization (PAHO) (2011) C_WHO

Download (375)

View PDF (423)

Lignes directrices por le traitement de la tuberculose sensible aux médicaments et la prise en charge du patient

Organisation mondiale de la Santé (2017) C_WHO

mise à Jour 2017

Download (243)

View PDF (388)

Considerations for selection of SARS-CoV-2 diagnostics and potential multiplexing: A perspective to ensure continuity of care for people with TB

Stop TB Partnership; WHO (2020) C_WHO

Download (662)

View PDF (689)

Achieving quality universal health coverage through better water, sanitation and hygiene services in health care facilities: A focus on Ethiopia

World Health Organization (WHO) (2017) C_WHO

A two-week mission was conducted by WASH and quality UHC technical experts from WHO headquarters and supported by the WHO Ethiopia Country Office (WASH and health systems teams) in July 2016, to understand how change in WASH services and quality improvements have been implemented in Ethiopia at nati... more

Download (372)

View PDF (560)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (497)

View PDF (503)

Health Sector Response to Gender Based Violence - Standard Operating Procedures for First Contact Point Health Care Providers - Sri Lanka

Ministry of Health, Nutrition & Indigenous Medicine (2019) CC

The United Nations Population Fund (UNFPA) is the lead UN agency working to further gender equality and women’s empowerment in Sri Lanka. We are pleased to be a part of the joint effort with the Ministry of Health to develop the first ‘Standard Operating Procedures on sexual and gender-based vio... more

Download (303)

View PDF (428)

Recommended package of interventions for HIV, viral hepatis and STI prevention, diagnosis, treatment and care for people who inject drugs: policy brief

World Health Organisation (WHO) (2023) C_WHO

HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination... more

External Link

The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients

Gyssens I. C., W. V. Kern, D. M. Livermore Haematologica (2013) C2

Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr... more

Download (496)

View PDF (549)

Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response at the health care facility level

World Health Organization WHO (2022) C_WHO

Infectious disease outbreaks and epidemics are increasing in frequency, scale and impact. Health care facilities can amplify the transmission of emerging infectious diseases or multidrug-resistant organisms (MDRO) within their settings and communities. Therefore, evidence-based infection prevention ... more

Download (1645)

View PDF (2857)

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended